The Board of Directors of Complete Genomics sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance and oversight. It is the duty of the Board of Directors to serve as a prudent fiduciary for stockholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in the corporate governance guidelines available below. The Board of Directors has also adopted a Code of Business Conduct and Ethics that applies to all of the Company’s directors, officers and employees. In addition, each of the three standing committees operates under a written charter approved by the Board of Directors and in accordance with the rules and regulations of The NASDAQ Stock Market.
The guidelines, code of business conduct and committee charters are each subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
| Document | View | ||
|---|---|---|---|
| Corporate Governance Guidelines |
39.9 KB
|
||
| Code of Business Conduct and Ethics |
53.2 KB
|
||
| Audit Committee Charter |
29.7 KB
|
||
| Compensation Committee Charter |
96.0 KB
|
||
| Nominating and Corporate Governance Committee Charter |
19.6 KB
|
||